ProQR Therapeutics NV (PRQR)
3.62
+0.01
(+0.28%)
USD |
NASDAQ |
Nov 22, 16:00
3.63
+0.01
(+0.28%)
After-Hours: 20:00
ProQR Therapeutics Profit Margin (Quarterly): -211.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -211.0% |
| June 30, 2024 | -42.70% |
| March 31, 2024 | -172.1% |
| December 31, 2023 | -167.0% |
| September 30, 2023 | -416.8% |
| June 30, 2023 | -663.3% |
| March 31, 2023 | -1.36K% |
| Date | Value |
|---|---|
| December 31, 2022 | -1.85K% |
| September 30, 2022 | -2.86K% |
| June 30, 2022 | -1.47K% |
| March 31, 2022 | -1.25K% |
| December 31, 2021 | -7.88K% |
| September 30, 2021 | -1.73K% |
| June 30, 2021 | -6.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.88K%
Minimum
Dec 2021
-42.70%
Maximum
Jun 2024
-1.90K%
Average
-1.31K%
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -1.94K% |
| Merus NV | -848.7% |
| argenx SE | 15.95% |
| Pharming Group | -1.38% |
| Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.59% |
| Return on Assets | -19.08% |
| Return on Invested Capital | -59.09% |
| Operating Margin (Quarterly) | -230.4% |
| Return on Net Operating Assets | -74.15% |